Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> LUNG CANCER Latest News

1 HOUR AGO - Yahoo! News

A Must Read - Share

Merck's Keytruda shrinks lung cancer tumors, FDA approval sought

Merck & Co Inc's Keytruda, approved for treating melanoma, was shown in a trial to shrink tumors in nearly half of advanced lung cancer patients with high levels of a protein used by tumors to evade the body's own disease-fighting cells. The company said it has filed for U.S. Food and Drug Administration approval of the drug as a treatment ...

Tags: Merck's Keytruda shrinks lung cancer tumors, FDA approval sought,  Lung Cancer Latest News

1 HOUR AGO - Yahoo! News

A Must Read - Share

Merck files for FDA approval of Keytruda in lung cancer

Merck & Co Inc said on Sunday it has submitted an application to the U.S. Food and Drug Administration for its drug Keytruda as a treatment for advanced non-small cell lung cancer, the most common form of the disease. Keytruda, also known as pembrolizumab, is currently approved by the FDA for patients with advanced melanoma who are no longer responding ...

Tags: Merck files for FDA approval of Keytruda in lung cancer,  Lung Cancer Latest News

17 HOURS AGO - MedPage Today

A Must Read - Share

EGFR Mutation Testing in Advanced Lung Cancer Underused

(MedPage Today) -- Patients may not receive the best treatment as a result, researchers worry.

Tags: EGFR Mutation Testing in Advanced Lung Cancer Underused,  Lung Cancer Latest News

APR 17, 2015 - Yahoo! News

A Must Read - Share

Bristol's Opdivo proves effective against second type of lung cancer

(Reuters) - A large study of Bristol-Myers Squibb Co's Opdivo treatment has been halted after proving the drug is effective against a common form of lung cancer, the company said, positioning the medicine for far wider use than its already approved lung cancer and melanoma indications. The U.S. drugmaker on Friday said the study was stopped early after an independent ...

Tags: Bristol's Opdivo proves effective against second type of lung cancer,  Lung Cancer Latest News

APR 17, 2015 - Yahoo! News

A Must Read - Share

AstraZeneca lung cancer drug delays disease by more than a year

AZD9291, which the company expects to file for U.S. approval in the second quarter of 2015, is one of a number of cancer medicines AstraZeneca is hoping will rebuild its sales following patent losses on older drugs. An analysis presented at the European Lung Cancer Conference in Geneva demonstrated a median progression-free survival for patients on the drug of 13.5 ...

Tags: AstraZeneca lung cancer drug delays disease by more than a year,  Lung Cancer Latest News